Licensing agreement
TG Therapeutics Partners with Neuraxpharm to Launch Game-Changing Multiple Sclerosis Antibody Briumvi Worldwide
SG Tylor
After gaining approval for Briumvi in the US eight months ago, TG Therapeutics is now set to introduce its multiple ...
